World's Best Scientists 2026 revealed!
Parameswaran Nair

Parameswaran Nair

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Microbiology 62 2831 2593 76 68 279 18890

Parameswaran Nair publications per year

The chart shows the history of publications by Parameswaran Nair between 2008 and 2026, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Parameswaran Nair published across 19 years, from 2008 to 2026, averaging 21.9 papers a year. Output peaked at 40 publications in 2024. 39 of the 416 publications appeared in the last two years.

No. of publications
10 20 30 40
Bar chart. Horizontal axis: year, 2008 to 2026. Vertical axis: number of publications, 0 to 40. Peak 40 publications in 2024. 2008: 12 publications 2009: 9 publications 2010: 12 publications 2011: 24 publications 2012: 16 publications 2013: 22 publications 2014: 13 publications 2015: 20 publications 2016: 17 publications 2017: 26 publications 2018: 15 publications 2019: 28 publications 2020: 30 publications 2021: 38 publications 2022: 25 publications 2023: 30 publications 2024: 40 publications 2025: 38 publications 2026: 1 publication
2008 2026

416 publications in total across all disciplines

View publications per year as a table
Parameswaran Nair: publications per year, 2008 to 2026
Year Publications
2008 12
2009 9
2010 12
2011 24
2012 16
2013 22
2014 13
2015 20
2016 17
2017 26
2018 15
2019 28
2020 30
2021 38
2022 25
2023 30
2024 40
2025 38
2026 1
Total 416
Download as CSV

Parameswaran Nair publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Parameswaran Nair sits on this spectrum.

No. of scientists
50 100 150 200 250
Bar chart with 64 bars. Horizontal axis: publications, 55–64 to 679+. Vertical axis: number of scientists, 0 to 288. Most scientists, 288, have 135–144 publications. The last bar groups every scientist with 679 publications or more. The highlighted bar, 275–284 publications, is where this scientist sits. 55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55–64 publications 679+

This scientist: 279 publications — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

View publications distribution as a table
Number of Microbiology scientists by publication count, Research.com 2026 ranking edition. Based on 5,513 ranked scientists.
Publications Scientists This scientist
55–64 8
65–74 29
75–84 55
85–94 112
95–104 137
105–114 190
115–124 235
125–134 234
135–144 288
145–154 265
155–164 264
165–174 253
175–184 276
185–194 190
195–204 234
205–214 208
215–224 198
225–234 155
235–244 161
245–254 160
255–264 146
265–274 139
275–284 148 279
285–294 115
295–304 96
305–314 88
315–324 106
325–334 65
335–344 76
345–354 64
355–364 62
365–374 65
375–384 61
385–394 34
395–404 44
405–414 36
415–424 35
425–434 29
435–444 33
445–454 34
455–464 25
465–474 26
475–484 20
485–494 19
495–504 16
505–514 17
515–524 23
525–534 14
535–544 14
545–554 18
555–564 12
565–574 7
575–584 9
585–594 9
595–604 9
605–614 7
615–624 9
625–634 7
635–644 4
645–654 5
655–664 6
665–674 7
675–678 3
679+ 99
Download as CSV

Parameswaran Nair D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Parameswaran Nair sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 88 bars. Horizontal axis: D-Index, 40 to 127+. Vertical axis: number of scientists, 0 to 162. Most scientists, 162, have 58 D-Index. The last bar groups every scientist with 127 D-Index or more. The highlighted bar, 62 D-Index, is where this scientist sits. 40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 62 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

View D-Index distribution as a table
Number of Microbiology scientists by D-index, Research.com 2026 ranking edition. Based on 5,513 ranked scientists.
D-Index Scientists This scientist
40 30
41 86
42 90
43 117
44 122
45 123
46 108
47 110
48 106
49 109
50 129
51 111
52 116
53 127
54 134
55 134
56 112
57 136
58 162
59 151
60 139
61 123
62 126 62
63 144
64 109
65 103
66 124
67 112
68 103
69 131
70 94
71 93
72 96
73 92
74 80
75 66
76 87
77 60
78 73
79 59
80 57
81 55
82 47
83 77
84 50
85 45
86 42
87 41
88 32
89 38
90 35
91 34
92 27
93 26
94 33
95 22
96 37
97 22
98 21
99 22
100 30
101 16
102 20
103 17
104 19
105 16
106 19
107 18
108 14
109 10
110 9
111 7
112 11
113 6
114 15
115 10
116 12
117 7
118 10
119 10
120 11
121 2
122 7
123 12
124 5
125 9
126 6
127+ 95
Download as CSV

Overview

Parameswaran Nair is affiliated with McMaster University in Canada and specializes in medical research, with a primary focus on pulmonary and respiratory medicine. Their scholarly activity encompasses 334 publications in medicine, with substantial contributions to several subfields including pulmonary and respiratory medicine, physiology, immunology, surgery, and rheumatology.

Their research mainly addresses topics within respiratory health and diseases, covering a range of key areas such as:

  • Asthma and respiratory diseases
  • Respiratory and cough-related research
  • Eosinophilic esophagitis
  • IL-33, ST2, and ILC pathways
  • Eosinophilic disorders and syndromes
  • Chronic obstructive pulmonary disease (COPD) research
  • Allergic rhinitis and sensitization

Parameswaran Nair's research output includes a number of recent papers demonstrating an emphasis on asthma and respiratory immune responses. Notable publications include:

  • "Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma" (2020, Allergy)
  • "EAACI Biologicals Guidelines-Recommendations for severe asthma" (2020, Allergy)
  • "Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long-COVID symptoms" (2022, European Respiratory Journal)
  • "Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis" (2022, The Journal of Allergy and Clinical Immunology In Practice)
  • "Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis/mycoses" (2024, European Respiratory Journal)

The scholar frequently collaborates with other researchers in their field. The five most frequent coauthors are:

  • Manali Mukherjee
  • Melanie Kjarsgaard
  • Sarah Svenningsen
  • Katherine Radford
  • Chynna Huang

Their work appears regularly in leading publication venues including:

  • Allergy
  • American Journal of Respiratory and Critical Care Medicine
  • CHEST Journal
  • European Respiratory Journal
  • Journal of Allergy and Clinical Immunology

In addition to journal articles, Parameswaran Nair has contributed to the book sector with a publication titled "Mucus plugging in severe asthma" (2025) under the European Respiratory Society.

Best Publications

  • Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia

    Parameswaran Nair;Marcia M M Pizzichini;Melanie Kjarsgaard;Mark D Inman

  • Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial

    J Mark FitzGerald;Eugene R Bleecker;Parameswaran Nair;Stephanie Korn

  • Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma.

    Klaus F. Rabe;Parameswaran Nair;Guy Brusselle;Jorge F. Maspero

  • Oral Glucocorticoid-Sparing Effect of Benralizumab in Severe Asthma.

    Parameswaran Nair;Sally Wenzel;Klaus F. Rabe;Arnaud Bourdin

  • Reslizumab for Poorly Controlled, Eosinophilic Asthma: A Randomized, Placebo-Controlled Study

    Mario Castro;Sameer Mathur;Frederick Hargreave;Louis-Philippe Boulet

  • Omalizumab for asthma in adults and children.

    Rebecca Normansell;Samantha Walker;Stephen J Milan;E. Haydn Walters

  • Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia.

    Steven G. Smith;Ruchong Chen;Ruchong Chen;Melanie Kjarsgaard;Chynna Huang

  • Role of Biologics in Asthma.

    Mary Clare McGregor;James G. Krings;Parameswaran Nair;Mario Castro

  • Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo‐controlled clinical trial

    P. Nair;M. Gaga;E. Zervas;K. Alagha

  • Revisiting Type 2‐high and Type 2‐low airway inflammation in asthma: current knowledge and therapeutic implications

    D. Robinson;M. Humbert;R. Buhl;A. A. Cruz

  • Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma

    Ioana Agache;Jessica Beltran;Cezmi Akdis;Mubeccel Akdis

  • Addition of intravenous aminophylline to inhaled beta2-agonists in adults with acute asthma

    Parameswaran Nair;Stephen J Milan;Brian H Rowe

  • Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis.

    Unknown

  • Asthma Endotypes and an Overview of Targeted Therapy for Asthma.

    Sarah Svenningsen;Parameswaran Nair

  • Efficacy and safety of a CXCR2 antagonist, AZD5069, in patients with uncontrolled persistent asthma: a randomised, double-blind, placebo-controlled trial.

    Paul M O'Byrne;Hristo Metev;Margareta Puu;Kai Richter

  • Mechanisms and therapeutic strategies for Non‐T2 Asthma

    Eric Sze;Eric Sze;Anurag Bhalla;Parameswaran Nair

  • EAACI Biologicals Guidelines—Recommendations for severe asthma

    Ioana Agache;Cezmi Akdis;Mubeccel Akdis;Giorgio Walter Canonica

  • Methacholine test and the diagnosis of asthma.

    Donald W. Cockcroft;Parameswaran Nair

  • The definition and diagnosis of asthma.

    F. E. Hargreave;P. Nair

  • Weight-adjusted Intravenous Reslizumab in Severe Asthma with Inadequate Response to Fixed-Dose Subcutaneous Mepolizumab

    Manali Mukherjee;Fernando Aleman Paramo;Melanie Kjarsgaard;Brittany Salter

  • The Safety of Long-Acting β-Agonists among Patients with Asthma Using Inhaled Corticosteroids

    Roman Jaeschke;Paul M. O'Byrne;Filip Mejza;Parameswaran Nair

Frequent Co-Authors

Paul M. O'Byrne
Paul M. O'Byrne McMaster University
Frederick E. Hargreave
Frederick E. Hargreave McMaster University
Louis-Philippe Boulet
Louis-Philippe Boulet Université Laval
Qutayba Hamid
Qutayba Hamid University of Sharjah
James G. Martin
James G. Martin McGill University Health Centre
James J. Lee
James J. Lee Mayo Clinic
Catherine Lemière
Catherine Lemière University of Montreal
Gail M. Gauvreau
Gail M. Gauvreau McMaster University
Nikolaos G. Papadopoulos
Nikolaos G. Papadopoulos National and Kapodistrian University of Athens
Mohamed H. Shamji
Mohamed H. Shamji Imperial College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Microbiology in the USA opens doors to diverse healthcare careers. As the industry increasingly relies on digital data, roles such as health information management have grown in demand. Understanding the health information manager salary can offer valuable insight into potential earnings and career trajectories in this field.

For those interested in specialized education, exploring online health information management degree programs cahiim accredited is essential. Accreditation ensures quality and industry relevance, which is critical for advancing in medical data administration and compliance roles.

Additionally, quick certification pathways such as fast online medical billing and coding certification programs provide an efficient route to enter the healthcare administration sector. These certifications complement microbiology knowledge by enabling professionals to manage coding and billing with accuracy.

Broadening your scope, numerous online healthcare degrees allow for flexible learning and specialization. These options support career advancement by combining scientific expertise with healthcare management skills, making graduates highly competitive in the job market.

Best Scientists Citing Parameswaran Nair

Trending Scientists

Recently Published Articles